bioAffinity Technologies (BIAF) Net Margin (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Net Margin of 268.63% for Q1 2026, down 12510.0% year-over-year from N/an in Q1 2025, and down 36.38% quarter-over-quarter from 196.98% in Q4 2025.
bioAffinity Technologies (BIAF) Net Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Net Margin for 5 consecutive years, with 268.63% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin fell 12510.0% year-over-year to 268.63%; the TTM figure through Mar 2026 stood at 280.57% (down 17002.0% YoY), while the FY2025 annual figure was 241.96%, down 14541.0% from the prior year.
- Net Margin retreated to 268.63% in Q1 2026 per BIAF's latest filing, from 196.98% in the prior quarter.
- Across five years, Net Margin topped out at 81.53% in Q1 2024 and bottomed at 427778.96% in Q3 2022.
- Historically, Net Margin has averaged 42730.41% across 5 years, with a median of 294.25% in 2025.
- On a YoY basis, Net Margin climbed as much as 42701145 bps in 2023 and fell as far as 207425 bps in 2023.
- bioAffinity Technologies' Net Margin stood at 71380.35% in 2022, then soared by 100 bps to 107.22% in 2023, then retreated by 25 bps to 134.4% in 2024, then tumbled by 47 bps to 196.98% in 2025, then slumped by 36 bps to 268.63% in 2026.
- Business Quant data shows BIAF's Net Margin at 268.63% in Q1 2026, 196.98% in Q4 2025, and 349.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 13.89% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 27.82% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.52% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.22% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 22.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.65% |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | -268.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268.63% |
| Dec 31, 2025 | -196.98% |
| Sep 30, 2025 | -349.30% |
| Jun 30, 2025 | -319.88% |
| Mar 31, 2025 | -143.53% |
| Dec 31, 2024 | -134.40% |
| Sep 30, 2024 | -85.13% |
| Jun 30, 2024 | -88.01% |
| Mar 31, 2024 | -81.53% |
| Dec 31, 2023 | -107.22% |
| Sep 30, 2023 | -767.51% |
| Jun 30, 2023 | -8,816.36% |
| Mar 31, 2023 | -166,426.71% |
| Dec 31, 2022 | -71,380.35% |
| Sep 30, 2022 | -427,778.96% |
| Jun 30, 2022 | -6,742.11% |